Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Herrmann

Showing results (611-620 of 721) with videos related to

Pageof 73
Sort By:
European Journal of Radiology|May 7, 2020
Impact of <sup>18</sup>F-FDG PET/MR on therapeutic management in high risk primary breast cancer patients - A prospective evaluation of staging algorithmsJulian Kirchner, Ole Martin, Lale Umutlu, et al.
Cancers|April 12, 2022
Multiparametric <sup>18</sup>F-FDG PET/MRI-Based Radiomics for Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast CancerLale Umutlu, Julian Kirchner, Nils-Martin Bruckmann, et al.
Scientific Reports|October 20, 2022
Prediction of malignant lymph nodes in NSCLC by machine-learning classifiers using EBUS-TBNA and PET/CTMaja Guberina, Ken Herrmann, Christoph Pöttgen, et al.
European Urology|March 19, 2023
Second Version of the Prostate Cancer Molecular Imaging Standardized Evaluation Framework Including Response Evaluation for Clinical Trials (PROMISE V2)Robert Seifert, Louise Emmett, Steven P Rowe, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 3, 2021
Comparison of nodal staging between CT, MRI, and [<sup>18</sup>F]-FDG PET/MRI in patients with newly diagnosed breast cancerJanna Morawitz, Nils-Martin Bruckmann, Frederic Dietzel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 8, 2026
Prognostic Value of Fibroblast Activation Protein-Directed PET Imaging in Pleural MesotheliomaLukas Kessler, Felix Schwaning, Martin Metzenmacher, et al.
Frontiers in Aging Neuroscience|September 2, 2014
Nicotinic acetylcholine receptor density in cognitively intact subjects at an early stage of Parkinson's diseaseIoannis Ugo Isaias, Jörg Spiegel, Joachim Brumberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 15, 2023
SUV<sub>max</sub> Above 20 in <sup>18</sup>F-FDG PET/CT at Initial Diagnostic Workup Associates with Favorable Survival in Patients with Cancer of Unknown PrimaryGregor Zaun, Manuel Weber, Martin Metzenmacher, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 19, 2020
False positive PSMA PET for tumor remnants in the irradiated prostate and other interpretation pitfalls in a prospective multi-center trialWolfgang P Fendler, Jeremie Calais, Matthias Eiber, et al.
Hemasphere|January 26, 2023
Outcome Prediction in Patients With Large B-cell Lymphoma Undergoing Chimeric Antigen Receptor T-cell TherapyConrad-Amadeus Voltin, Philipp Gödel, Laura Beckmann, et al.
Pageof 73

Showing results (611-620 of 721) with videos related to

Sort By:
Pageof 73
European Journal of Radiology|May 7, 2020
Impact of <sup>18</sup>F-FDG PET/MR on therapeutic management in high risk primary breast cancer patients - A prospective evaluation of staging algorithmsJulian Kirchner, Ole Martin, Lale Umutlu, et al.
Cancers|April 12, 2022
Multiparametric <sup>18</sup>F-FDG PET/MRI-Based Radiomics for Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast CancerLale Umutlu, Julian Kirchner, Nils-Martin Bruckmann, et al.
Scientific Reports|October 20, 2022
Prediction of malignant lymph nodes in NSCLC by machine-learning classifiers using EBUS-TBNA and PET/CTMaja Guberina, Ken Herrmann, Christoph Pöttgen, et al.
European Urology|March 19, 2023
Second Version of the Prostate Cancer Molecular Imaging Standardized Evaluation Framework Including Response Evaluation for Clinical Trials (PROMISE V2)Robert Seifert, Louise Emmett, Steven P Rowe, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 3, 2021
Comparison of nodal staging between CT, MRI, and [<sup>18</sup>F]-FDG PET/MRI in patients with newly diagnosed breast cancerJanna Morawitz, Nils-Martin Bruckmann, Frederic Dietzel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 8, 2026
Prognostic Value of Fibroblast Activation Protein-Directed PET Imaging in Pleural MesotheliomaLukas Kessler, Felix Schwaning, Martin Metzenmacher, et al.
Frontiers in Aging Neuroscience|September 2, 2014
Nicotinic acetylcholine receptor density in cognitively intact subjects at an early stage of Parkinson's diseaseIoannis Ugo Isaias, Jörg Spiegel, Joachim Brumberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 15, 2023
SUV<sub>max</sub> Above 20 in <sup>18</sup>F-FDG PET/CT at Initial Diagnostic Workup Associates with Favorable Survival in Patients with Cancer of Unknown PrimaryGregor Zaun, Manuel Weber, Martin Metzenmacher, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 19, 2020
False positive PSMA PET for tumor remnants in the irradiated prostate and other interpretation pitfalls in a prospective multi-center trialWolfgang P Fendler, Jeremie Calais, Matthias Eiber, et al.
Hemasphere|January 26, 2023
Outcome Prediction in Patients With Large B-cell Lymphoma Undergoing Chimeric Antigen Receptor T-cell TherapyConrad-Amadeus Voltin, Philipp Gödel, Laura Beckmann, et al.
Pageof 73